What's in Nuvation Bio Inc.'s pipeline?

Nuvation Bio Inc. has 6 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 5 in Phase 1.

Which companies overlap with Nuvation Bio Inc.'s portfolio?

Top competitors by shared drug class: Advenchen Laboratories, LLC, Dong-A ST Co., Ltd., Elion Therapeutics, Inc., Hadassah Medical Organization, Hatem AbuHashim.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/nuvation-bio-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

Nuvation Bio Inc. — Portfolio Competitive Intelligence Brief

Nuvation Bio Inc. pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 5 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Infectious Disease · 2
Cardiovascular · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Advenchen Laboratories, LLC · 1 shared drug class
Dong-A ST Co., Ltd. · 1 shared drug class
Elion Therapeutics, Inc. · 1 shared drug class
Hadassah Medical Organization · 1 shared drug class
Hatem AbuHashim · 1 shared drug class
Janssen Pharmaceutical K.K. · 1 shared drug class
Jiangsu Aosaikang Pharmaceutical Co., Ltd. · 1 shared drug class
Meir Medical Center · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Nuvation Bio Inc.:

Cite this brief

Drug Landscape (2026). Nuvation Bio Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nuvation-bio-inc. Accessed 2026-05-14.